|
Ridley, R C; Xiao, H; Hata, H et al. (1993) Expression of syndecan regulates human myeloma plasma cell adhesion to type I collagen. Blood 81:767-74
|
|
Hata, H; Xiao, H; Petrucci, M T et al. (1993) Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells. Blood 81:3357-64
|
|
Kreitman, R J; Siegall, C B; FitzGerald, D J et al. (1992) Interleukin-6 fused to a mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma. Blood 79:1775-80
|
|
Thomas, X; Xiao, H Q; Chang, R et al. (1992) Circulating B lymphocytes in multiple myeloma patients contain an autocrine IL-6 driven pre-myeloma cell population. Curr Top Microbiol Immunol 182:201-7
|
|
Barlogie, B; Gale, R P (1992) Multiple myeloma and chronic lymphocytic leukemia: parallels and contrasts. Am J Med 93:443-50
|
|
Jagannath, S; Vesole, D H; Glenn, L et al. (1992) Low-risk intensive therapy for multiple myeloma with combined autologous bone marrow and blood stem cell support. Blood 80:1666-72
|
|
Alexanian, R; Barlogie, B; Gutterman, J (1991) Alpha-interferon combination therapy of resistant myeloma. Am J Clin Oncol 14:188-92
|
|
Barlogie, B; Gahrton, G (1991) Bone marrow transplantation in multiple myeloma. Bone Marrow Transplant 7:71-9
|
|
Dimopoulos, M A; Barlogie, B; Smith, T L et al. (1991) High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myeloma. Ann Intern Med 115:931-5
|
|
Barlogie, B; Jagannath, S; Dixon, D O et al. (1990) High-dose melphalan and granulocyte-macrophage colony-stimulating factor for refractory multiple myeloma. Blood 76:677-80
|
Showing the most recent 10 out of 39 publications
